In the latest trading session,, 1.04 million Tenet Healthcare Corp (NYSE:THC) shares changed hands as the company’s beta touched 1.65. With the company’s most recent per share price at $133.82 changing hands around $9.91 or 8.00% at last look, the market valuation stands at $12.63B. THC’s current price is a discount, trading about -27.93% off its 52-week high of $171.20. The share price had its 52-week low at $96.14, which suggests the last value was 28.16% up since then. When we look at Tenet Healthcare Corp’s average trading volume, we note the 10-day average is 1.42 million shares, with the 3-month average coming to 1.65 million.
Analysts gave the Tenet Healthcare Corp (THC) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.52. If we narrow down to specifics, the data shows that 0 out of 10 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 0 recommended THC as a Hold, 9 felt it is a Buy and 0 rated the stock as Underweight. Tenet Healthcare Corp’s EPS for the current quarter is expected to be 2.64.
Tenet Healthcare Corp (NYSE:THC) trade information
Instantly THC is in green as seen in intraday trades today. With action 16.69%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 6.02%, with the 5-day performance at 16.69% in the green. However, in the 30-day time frame, Tenet Healthcare Corp (NYSE:THC) is 0.51% up. Looking at the short shares, we see there were 1.82 million shares sold at short interest cover period of 1.06 days.
The consensus price target for the stock as assigned by Wall Street analysts is 165, meaning bulls need an upside of 18.9% from its recent market value. According to analyst projections, THC’s forecast low is 140 with 185 as the target high. To hit the forecast high, the stock’s price needs a -38.25% plunge from its current level, while the stock would need to soar -4.62% for it to hit the projected low.
Tenet Healthcare Corp (THC) estimates and forecasts
Year-over-year growth is forecast to reach 1.01% up from the last financial year.
Consensus estimates given by 17 financial analysts project the company’s revenue in the current quarter to hit an average of 5.14B. 17 analysts are of the opinion that Tenet Healthcare Corp’s revenue for the current quarter will be 5.17B. The company’s revenue for the corresponding quarters a year ago was 5.1B and 5.12B respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.73%. The estimates for the next quarter sales put growth at 1.02%.
The 2025 estimates are for Tenet Healthcare Corp earnings to increase by 2.36%, but the outlook for the next 5-year period is at 8.66% per year.
THC Dividends
Tenet Healthcare Corp is expected to release its next quarterly earnings report on 2025-Feb-11. During the past 5 years, the average dividend yield was 2.75 per year.
Tenet Healthcare Corp (NYSE:THC)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.76% of Tenet Healthcare Corp shares while 99.43% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 100.19%. There are 99.43% institutions holding the Tenet Healthcare Corp stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 10.6688% of the shares, roughly 10.38 million THC shares worth $1.38 billion.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 10.1619% or 9.88 million shares worth $1.31 billion as of 2024-06-30.
Among Mutual Funds, the top two as of Jan 31, 2025 were Pacer Funds Trust-Pacer US Cash Cows 100 ETF and iShares Trust-iShares Core S&P Mid-Cap ETF . With 3.78 shares estimated at $504.39 million under it, the former controlled 4.00% of total outstanding shares. On the other hand, iShares Trust-iShares Core S&P Mid-Cap ETF held about 3.29% of the shares, roughly 3.11 shares worth around $414.76 million.
